Point72 Hong Kong’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Point72 Hong Kong’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,034	Closed	-$31K	–	2515
2022 Q1	$31K	Buy	2,034 +1,031	+103%	+$16.1K	﹤0.01%	1454
2021 Q4	$18K	Buy	+1,003	New	+$19.2K	﹤0.01%	1565
2021 Q2	–	Sell	-633	Closed	-$18K	–	2444
2021 Q1	$18K	Buy	+633	New	+$17.7K	﹤0.01%	1500
2020 Q4	–	Sell	-989	Closed	-$16K	–	2113
2020 Q3	$16K	Buy	+989	New	+$18K	﹤0.01%	917
2020 Q2	–	Sell	-774	Closed	-$10K	–	1493
2020 Q1	$10K	Buy	+774	New	+$12.6K	﹤0.01%	689

Other funds holding NGM

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PIM

Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Point72 Hong Kong's NGM Position: Q2 2022 in Review

Point72 Hong Kong sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2022, closing a stake of 2,034 shares — an estimated $31K sold.

Point72 Hong Kong first reported a position in NGM in Q1 2020 and held it in 5 quarters. The position peaked at $31K in Q1 2022. 123 funds tracked by Wall St. Rank hold NGM as of Q2 2022.

Point72 Hong Kong reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Point72 Hong Kong sold 2,034 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $31K.
Point72 Hong Kong first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
Point72 Hong Kong's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $31K in Q1 2022.
123 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.